563 related articles for article (PubMed ID: 870773)
21. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.
Wisgerhof M; Brown RD
J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808
[TBL] [Abstract][Full Text] [Related]
22. [Behavior of the plasma renin activity and aldosterone after salt restriction and upright posture in essential hypertension].
Kokot F; Kuska J; Chorqzy M
Z Gesamte Inn Med; 1976 Dec; 31(24):1016-20. PubMed ID: 1020406
[TBL] [Abstract][Full Text] [Related]
23. [Is there a relation between the renin-angiotensin-aldosterone system and vasopressin secretion in essential hypertension?].
Wiecek A; Kokot F
Z Gesamte Inn Med; 1984 Dec; 39(23):578-82. PubMed ID: 6396982
[TBL] [Abstract][Full Text] [Related]
24. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
[TBL] [Abstract][Full Text] [Related]
25. Aldosterone responsiveness to angiotensin II after sodium restriction in subjects with low renin essential hypertension.
Takeda R; Morimoto S; Uchida K; Hashiba T; Kigoshi T; Honjo A; Fujimura A
Clin Exp Hypertens A; 1982; 4(6):937-49. PubMed ID: 7047005
[TBL] [Abstract][Full Text] [Related]
26. Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes.
Douglas J; Catt KJ
J Clin Invest; 1976 Oct; 58(4):834-43. PubMed ID: 965491
[TBL] [Abstract][Full Text] [Related]
27. Abnormal norepinephrine and aldosterone responses to upright posture in nonmodulating hypertension.
Conlin PR; Braley LM; Menachery AI; Hollenberg NK; Williams GH
J Clin Endocrinol Metab; 1992 Oct; 75(4):1017-21. PubMed ID: 1400865
[TBL] [Abstract][Full Text] [Related]
28. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
[TBL] [Abstract][Full Text] [Related]
29. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
[TBL] [Abstract][Full Text] [Related]
30. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
[TBL] [Abstract][Full Text] [Related]
31. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
Ruilope LM; Miranda B; Robles RG; Hammond TG; Sancho J; Romero JC; Rodicio JL
Postgrad Med J; 1986; 62 Suppl 1():90-3. PubMed ID: 3534868
[TBL] [Abstract][Full Text] [Related]
32. Influence of sodium intake on the reliability of active renin as a measure of the renin-angiotensin system in essential hypertension.
Hurwitz S; Potter B; Weiss RJ; Jeunemaitre X; Hopkins PN; Hunt SC; Litchfield WR; Williams GH
Am J Clin Pathol; 2001 Feb; 115(2):304-12. PubMed ID: 11211621
[TBL] [Abstract][Full Text] [Related]
33. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
[TBL] [Abstract][Full Text] [Related]
34. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
Williams GH; Braley LM; Underwood RH
J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059
[TBL] [Abstract][Full Text] [Related]
35. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
[TBL] [Abstract][Full Text] [Related]
37. The mechanism of low-renin hypertension: aldosterone response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients with hypertension.
Saito I; Saruta T; Nakamura R; Misumi J; Kondo K; Matsuki S
Jpn Circ J; 1976 Aug; 40(8):911-9. PubMed ID: 184308
[TBL] [Abstract][Full Text] [Related]
38. A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension.
Tuck ML; Williams GH; Dluhy RG; Greenfield M; Moore TJ
Circ Res; 1976 Nov; 39(5):711-7. PubMed ID: 975459
[TBL] [Abstract][Full Text] [Related]
39. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
Williams GH; Hollenberg NK
J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876
[TBL] [Abstract][Full Text] [Related]
40. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
Speckart P; Zia P; Zipser R; Horton R
J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
